BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsumoto Y, Itami S, Kuroda M, Yoshizato K, Kawada N, Murakami Y. MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice. Mol Ther. 2016;24:1848-1859. [PMID: 27480597 DOI: 10.1038/mt.2016.127] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Tai Y, Zhao C, Gao J, Lan T, Tong H. Identification of miRNA-target gene regulatory networks in liver fibrosis based on bioinformatics analysis. PeerJ 2021;9:e11910. [PMID: 34434654 DOI: 10.7717/peerj.11910] [Reference Citation Analysis]
2 Porcuna J, Mínguez-Martínez J, Ricote M. The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders. Int J Mol Sci 2021;22:10573. [PMID: 34638914 DOI: 10.3390/ijms221910573] [Reference Citation Analysis]
3 Xue H, Zhang G, Geurts AM, Usa K, Jensen DM, Liu Y, Widlansky ME, Liang M. Tissue-specific effects of targeted mutation of Mir29b1 in rats. EBioMedicine 2018;35:260-9. [PMID: 30120082 DOI: 10.1016/j.ebiom.2018.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Liu Y, Ren H, Wang J, Yang F, Li J, Zhou Y, Yuan X, Zhu W, Shi X. Prostaglandin E2 secreted by mesenchymal stem cells protects against acute liver failure via enhancing hepatocyte proliferation. FASEB J 2019;33:2514-25. [PMID: 30260707 DOI: 10.1096/fj.201801349RR] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
5 Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut 2021;70:784-95. [PMID: 33127832 DOI: 10.1136/gutjnl-2020-322526] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 79.0] [Reference Citation Analysis]
6 Liu J, Xiao Y, Wu X, Jiang L, Yang S, Ding Z, Fang Z, Hua H, Kirby MS, Shou J. A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis. BMC Genomics 2018;19:188. [PMID: 29523084 DOI: 10.1186/s12864-018-4575-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
7 Tadokoro T, Morishita A, Masaki T. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. Int J Mol Sci 2021;22:8139. [PMID: 34360904 DOI: 10.3390/ijms22158139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Yang X, Liang Y, Bamunuarachchi G, Xu Y, Vaddadi K, Pushparaj S, Xu D, Zhu Z, Blaha R, Huang C, Liu L. miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor. Arch Virol 2021;166:363-73. [PMID: 33206218 DOI: 10.1007/s00705-020-04877-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Horita M, Farquharson C, Stephen LA. The role of miR-29 family in disease. J Cell Biochem 2021;122:696-715. [PMID: 33529442 DOI: 10.1002/jcb.29896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Akbari Dilmaghnai N, Shoorei H, Sharifi G, Mohaqiq M, Majidpoor J, Dinger ME, Taheri M, Ghafouri-Fard S. Non-coding RNAs modulate function of extracellular matrix proteins. Biomed Pharmacother 2021;136:111240. [PMID: 33454598 DOI: 10.1016/j.biopha.2021.111240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ntelios D, Meditskou S, Efthimiadis G, Pitsis A, Nikolakaki E, Girtovitis F, Parcharidou D, Zegkos T, Kouidou S, Karvounis H, Tzimagiorgis G. Elevated plasma levels of miR-29a are associated with hemolysis in patients with hypertrophic cardiomyopathy. Clin Chim Acta 2017;471:321-6. [PMID: 28684219 DOI: 10.1016/j.cca.2017.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
12 Deng Z, He Y, Yang X, Shi H, Shi A, Lu L, He L. MicroRNA-29: A Crucial Player in Fibrotic Disease. Mol Diagn Ther 2017;21:285-94. [PMID: 28130757 DOI: 10.1007/s40291-016-0253-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
13 Tian Y, Zhan Y, Jiang Q, Lu W, Li X. Expression and function of PDGF-C in development and stem cells. Open Biol 2021;11:210268. [PMID: 34847773 DOI: 10.1098/rsob.210268] [Reference Citation Analysis]
14 Mohr R, Özdirik B, Lambrecht J, Demir M, Eschrich J, Geisler L, Hellberg T, Loosen SH, Luedde T, Tacke F, Hammerich L, Roderburg C. From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis. Int J Mol Sci 2021;22:1492. [PMID: 33540837 DOI: 10.3390/ijms22031492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Song YX, Ou YM, Zhou JY. Gracillin inhibits apoptosis and inflammation induced by lipopolysaccharide (LPS) to alleviate cardiac injury in mice via improving miR-29a. Biochem Biophys Res Commun 2020;523:580-7. [PMID: 31941605 DOI: 10.1016/j.bbrc.2019.11.129] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Ye L, Yu Y, Zhao Y. Icariin-induced miR-875-5p attenuates epithelial-mesenchymal transition by targeting hedgehog signaling in liver fibrosis. J Gastroenterol Hepatol 2020;35:482-91. [PMID: 31617598 DOI: 10.1111/jgh.14875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
17 Zhang AH, Jiang N, Wang XQ, Tan RX. Galewone, an Anti-Fibrotic Polyketide from Daldinia eschscholzii with an Undescribed Carbon Skeleton. Sci Rep 2019;9:14316. [PMID: 31586120 DOI: 10.1038/s41598-019-50868-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Su WH, Wang CJ, Hung YY, Lu CW, Ou CY, Tseng SH, Tsai CC, Kao YT, Chuang PC. MicroRNA-29a Exhibited Pro-Angiogenic and Anti-Fibrotic Features to Intensify Human Umbilical Cord Mesenchymal Stem Cells-Renovated Perfusion Recovery and Preventing against Fibrosis from Skeletal Muscle Ischemic Injury. Int J Mol Sci 2019;20:E5859. [PMID: 31766662 DOI: 10.3390/ijms20235859] [Reference Citation Analysis]
19 Zhu Y, Zhang Y, Jiang R, Zhao K, Zhou J. MicroRNA-29a May Influence Myopia Development by Regulating Collagen I. Curr Eye Res 2021;:1-9. [PMID: 34766525 DOI: 10.1080/02713683.2021.1998542] [Reference Citation Analysis]
20 Suzuki E, Kaneko S, Okusaka T, Ikeda M, Yamaguchi K, Sugimoto R, Aramaki T, Asagi A, Yasui K, Sano K, Hosokawa A, Kato N, Ishii H, Sato T, Furuse J. A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class. Japanese Journal of Clinical Oncology 2018;48:317-21. [DOI: 10.1093/jjco/hyy010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Dong XC, Chowdhury K, Huang M, Kim HG. Signal Transduction and Molecular Regulation in Fatty Liver Disease. Antioxid Redox Signal 2021. [PMID: 33906425 DOI: 10.1089/ars.2021.0076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Al-Taee KMK, Zepp M, Berger I, Berger MR, Adwan H. Pancreatic carcinoma cells colonizing the liver modulate the expression of their extracellular matrix genes. Genes Cancer 2018;9:215-31. [PMID: 30603057 DOI: 10.18632/genesandcancer.179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Wu HJ, Zhuo Y, Zhou YC, Wang XW, Wang YP, Si CY, Wang XH. miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma. World J Gastroenterol 2017; 23(25): 4569-4578 [PMID: 28740345 DOI: 10.3748/wjg.v23.i25.4569] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
24 Tao R, Fan XX, Yu HJ, Ai G, Zhang HY, Kong HY, Song QQ, Huang Y, Huang JQ, Ning Q. MicroRNA-29b-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting COL1A1 and COL3A1. J Cell Biochem 2018;119:3199-209. [PMID: 29091295 DOI: 10.1002/jcb.26475] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
25 Jhanji V, Billig I, Yam GH. Cell-Free Biological Approach for Corneal Stromal Wound Healing. Front Pharmacol 2021;12:671405. [PMID: 34122095 DOI: 10.3389/fphar.2021.671405] [Reference Citation Analysis]
26 Wan X, Chen S, Fang Y, Zuo W, Cui J, Xie S. Mesenchymal stem cell-derived extracellular vesicles suppress the fibroblast proliferation by downregulating FZD6 expression in fibroblasts via micrRNA-29b-3p in idiopathic pulmonary fibrosis. J Cell Physiol 2020;235:8613-25. [PMID: 32557673 DOI: 10.1002/jcp.29706] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
27 Yang YL, Wang FS, Lin HY, Huang YH. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha. Int J Mol Sci 2020;21:E3636. [PMID: 32455716 DOI: 10.3390/ijms21103636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
28 Liu J, Fei D, Xing J, Du J. MicroRNA-29a inhibits proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes by repressing STAT3. Biomed Pharmacother 2017;96:173-81. [PMID: 28987940 DOI: 10.1016/j.biopha.2017.09.120] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
29 Iacob DG, Rosca A, Ruta SM. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World J Gastroenterol 2020; 26(11): 1113-1127 [PMID: 32231417 DOI: 10.3748/wjg.v26.i11.1113] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
30 Chang N, Duan X, Zhao Z, Tian L, Ji X, Yang L, Li L. Both HuR and miR-29s regulate expression of CB1 involved in infiltration of bone marrow monocyte/macrophage in chronic liver injury. J Cell Physiol 2020;235:2532-44. [PMID: 31495934 DOI: 10.1002/jcp.29157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Zhao Z, Lin CY, Cheng K. siRNA- and miRNA-based therapeutics for liver fibrosis. Transl Res 2019;214:17-29. [PMID: 31476281 DOI: 10.1016/j.trsl.2019.07.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
32 Molenaar MR, Penning LC, Helms JB. Playing Jekyll and Hyde-The Dual Role of Lipids in Fatty Liver Disease. Cells 2020;9:E2244. [PMID: 33036257 DOI: 10.3390/cells9102244] [Reference Citation Analysis]
33 Lin HY, Yang YL, Wang PW, Wang FS, Huang YH. The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond. Cells 2020;9:E1041. [PMID: 32331364 DOI: 10.3390/cells9041041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
34 Bissoondial TL, Pellicano AJ, Goldberg ID, Narayan P. Identification of disease-associated microRNA in a diet-induced model of nonalcoholic steatohepatitis. Mol Omics 2021. [PMID: 34757352 DOI: 10.1039/d1mo00274k] [Reference Citation Analysis]
35 Piperigkou Z, Götte M, Theocharis AD, Karamanos NK. Insights into the key roles of epigenetics in matrix macromolecules-associated wound healing. Adv Drug Deliv Rev 2018;129:16-36. [PMID: 29079535 DOI: 10.1016/j.addr.2017.10.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]